<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1261"/><api:result><api:object category="publication" id="1261" last-affected-when="2024-04-20T18:27:15.42+01:00" last-modified-when="2024-04-20T18:27:15.42+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1261" created-when="2010-05-17T13:47:34.62+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2012-09-21</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="2449178" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.2165/00019053-200017050-00004" last-modified-when="2022-09-11T03:14:58.057+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1802" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1802"/></api:links><api:last-name>Brennan</api:last-name><api:initials>A</api:initials><api:first-names>Alan</api:first-names><api:separate-first-names><api:first-name>Alan</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Akehurst</api:last-name><api:initials>R</api:initials><api:first-names>Ron</api:first-names><api:separate-first-names><api:first-name>Ron</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017050-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017050-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017050-00004"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>445</api:begin-page><api:end-page>459</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.2165/00019053-200017050-00004</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>21</api:day><api:month>3</api:month><api:year>2019</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Modelling in Health Economic Evaluation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="95899" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034086528" last-modified-when="2024-02-28T09:44:33.1+00:00"><api:citation-count>121</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>This paper itemises the current and developing roles of modelling in health economic evaluation and discusses its value in each role. We begin by noting the emptiness of the dichotomy that some commentators have sought to create between modelling and controlled trials as mechanisms for informing decisions. Both are necessary parts of the armoury. Recent literature discussions are examined and the accelerating prevalence of modelling is reported. The identified roles include: extrapolating outcomes to the longer term; adjusting for prognostic factors in trials; translating from intermediate to final outcomes; extending analysis to the relevant comparators; generalising from specific trial populations to the full target group for an intervention and to other settings and countries; systematic sensitivity analyses; and the use of modelling for the design and prioritisation of future trials. Roles are illustrated with 20 recent examples, mostly from within our own work analysing new or contentious interventions for the Trent Development and Evaluation Committee, which is planned to be incorporated into the UK National Institute for Clinical Excellence (NICE). Each role discussed has been essential at some point in this policy-making forum. Finally, the importance of quality assurance, critical review and validity testing is reiterated and there are some observations on processes to ensure probity and quality.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1802" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1802"/></api:links><api:last-name>Brennan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Faculty of Medicine, Dentistry and Health</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55585019700</api:identifier></api:identifiers></api:person><api:person><api:last-name>Akehurst</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Faculty of Medicine, Dentistry and Health</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55518934300</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017050-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017050-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017050-00004"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10977387</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>445</api:begin-page><api:end-page>459</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Modelling in health economic evaluation: What is its place? What is its value?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Conference Proceeding</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="1261" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10977387" last-modified-when="2020-04-29T06:12:04.49+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>This paper itemizes the current and developing roles of modelling in health economic evaluation and discusses its value in each role. We begin by noting the emptiness of the dichotomy that some commentators have sought to create between modelling and controlled trials as mechanisms for informing decisions. Both are necessary parts of the armoury. Recent literature discussions are examined and the accelerating prevalence of modelling is reported. The identified roles include: extrapolating outcomes to the longer term; adjusting for prognostic factors in trials; translating from intermediate to final outcomes; extending analysis to the relevant comparators; generalizing from specific trial populations to the full target group for an intervention and to other settings and countries; systematic sensitivity analyses; and the use of modelling for the design and prioritization of future trials. Roles are illustrated with 20 recent examples, mostly from within our own work analysing new or contentious interventions for the Trent Development and Evaluation Committee, which is planned to be incorporated into the UK National Institute for Clinical Excellence (NICE). Each role discussed has been essential at some point in this policy-making forum. Finally, the importance of quality assurance, critical review and validity testing is reiterated and there are some observations on processes to ensure probity and quality.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1802" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1802"/></api:links><api:last-name>Brennan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">School of Health and Related Research (ScHARR), University of Sheffield, England. a.brennan@sheffield.ac.uk</api:line></api:address></api:addresses><api:email-address>a.brennan@sheffield.ac.uk</api:email-address></api:person><api:person><api:last-name>Akehurst</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10977387</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017050-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017050-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017050-00004"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Pharmacoeconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Biomedical Technology</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Models, Economic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>New Zealand</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>445</api:begin-page><api:end-page>459</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>10</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Modelling in health economic evaluation. What is its place? What is its value?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="882348" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10977387" last-modified-when="2024-03-12T19:47:11.6+00:00"><api:citation-count>72</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>This paper itemizes the current and developing roles of modelling in health economic evaluation and discusses its value in each role. We begin by noting the emptiness of the dichotomy that some commentators have sought to create between modelling and controlled trials as mechanisms for informing decisions. Both are necessary parts of the armoury. Recent literature discussions are examined and the accelerating prevalence of modelling is reported. The identified roles include: extrapolating outcomes to the longer term; adjusting for prognostic factors in trials; translating from intermediate to final outcomes; extending analysis to the relevant comparators; generalizing from specific trial populations to the full target group for an intervention and to other settings and countries; systematic sensitivity analyses; and the use of modelling for the design and prioritization of future trials. Roles are illustrated with 20 recent examples, mostly from within our own work analysing new or contentious interventions for the Trent Development and Evaluation Committee, which is planned to be incorporated into the UK National Institute for Clinical Excellence (NICE). Each role discussed has been essential at some point in this policy-making forum. Finally, the importance of quality assurance, critical review and validity testing is reiterated and there are some observations on processes to ensure probity and quality.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">School of Health and Related Research (ScHARR), University of Sheffield, England. a.brennan@sheffield.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1802" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1802"/></api:links><api:last-name>Brennan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-1025-312X</api:identifier></api:identifiers></api:person><api:person><api:last-name>Akehurst</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017050-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017050-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017050-00004"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1179-2027</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10977387</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Models, Economic</api:keyword><api:keyword scheme="mesh">Biomedical Technology</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>445</api:begin-page><api:end-page>459</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>8</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Modelling in health economic evaluation. What is its place? What is its value?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="2737458" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1031091640" last-modified-when="2024-04-13T19:13:21.14+01:00"><api:citation-count>121</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>9</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1802" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1802"/></api:links><api:last-name>Brennan</api:last-name><api:initials>A</api:initials><api:first-names>Alan</api:first-names><api:separate-first-names><api:first-name>Alan</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01272117136.54</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:last-name>Akehurst</api:last-name><api:initials>R</api:initials><api:first-names>Ron</api:first-names><api:separate-first-names><api:first-name>Ron</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0602212261.21</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017050-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017050-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017050-00004"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10977387</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>24.12</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">4203 Health Services and Systems</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">42 Health Sciences</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="rcdc">Clinical Trials and Supportive Activities</api:keyword><api:keyword scheme="hrcs-hc">Generic health relevance</api:keyword><api:keyword scheme="sdg">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh">Biomedical Technology</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Models, Economic</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>21</api:day><api:month>9</api:month><api:year>2012</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>445</api:begin-page><api:end-page>459</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>2.63</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Modelling in Health Economic Evaluation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="241735" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000087476400005" last-modified-when="2024-03-14T05:58:12.247+00:00"><api:citation-count>98</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1802" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1802"/></api:links><api:last-name>Brennan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Akehurst</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000087476400005&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017050-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017050-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017050-00004"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">321VY</api:identifier><api:identifier scheme="pubmed">10977387</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PHARMACOECONOMICS</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>445</api:begin-page><api:end-page>459</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Modelling in health economic evaluation - What is its place? What is its value?</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item><api:item>Proceedings Paper</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="24823" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000087476400005" last-modified-when="2014-07-25T11:08:29.86+01:00"><api:citation-count>31</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1802" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1802"/></api:links><api:last-name>Brennan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Akehurst</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PHARMACOECONOMICS</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>JOURNALS</api:keyword><api:keyword>CARE</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>445</api:begin-page><api:end-page>459</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Modelling in health economic evaluation - What is its place? What is its value?</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="1292814" source-id="12" source-name="repec" source-display-name="RePEc" id-at-source="RePEc:wkh:phecon:v:17:y:2000:i:5:p:445-459" suspected-deleted-at-source="true" last-modified-when="2024-04-09T15:52:21.533+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>This paper itemises the current and developing roles of modelling in health economic evaluation and discusses its value in each role. We begin by noting the emptiness of the dichotomy that some commentators have sought to create between modelling and controlled trials as mechanisms for informing decisions. Both are necessary parts of the armoury. Recent literature discussions are examined and the accelerating prevalence of modelling is reported. The identified roles include: extrapolating outcomes to the longer term; adjusting for prognostic factors in trials; translating from intermediate to final outcomes; extending analysis to the relevant comparators; generalising from specific trial populations to the full target group for an intervention and to other settings and countries; systematic sensitivity analyses; and the use of modelling for the design and prioritisation of future trials. Roles are illustrated with 20 recent examples, mostly from within our own work analysing new or contentious interventions for the Trent Development and Evaluation Committee, which is planned to be incorporated into the UK National Institute for Clinical Excellence (NICE). Each role discussed has been essential at some point in this policy-making forum. Finally, the importance of quality assurance, critical review and validity testing is reiterated and there are some observations on processes to ensure probity and quality.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address><api:line type="organisation">School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, England</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1802" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1802"/></api:links><api:last-name>Brennan</api:last-name><api:initials>A</api:initials><api:first-names>Alan</api:first-names><api:separate-first-names><api:first-name>Alan</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Akehurst</api:last-name><api:initials>R</api:initials><api:first-names>Ron</api:first-names><api:separate-first-names><api:first-name>Ron</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>C</api:keyword><api:keyword>D</api:keyword><api:keyword>I</api:keyword><api:keyword>Z</api:keyword><api:keyword>I1</api:keyword><api:keyword>I19</api:keyword><api:keyword>I18</api:keyword><api:keyword>I11</api:keyword><api:keyword>Modelling</api:keyword><api:keyword>Pharmacoeconomics</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>445</api:begin-page><api:end-page>459</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Modelling in Health Economic Evaluation: What is its Place? What is its Value?</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Biomedical Technology</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Models, Economic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Models, Economic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Biomedical Technology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">4203 Health Services and Systems</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">42 Health Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Trials and Supportive Activities</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Generic health relevance</api:keyword><api:keyword scheme="sdg" origin="record-data" source="dimensions">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Biomedical Technology</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Models, Economic</api:keyword><api:keyword origin="record-data" source="wos">JOURNALS</api:keyword><api:keyword origin="record-data" source="wos">CARE</api:keyword><api:keyword origin="record-data" source="repec">C</api:keyword><api:keyword origin="record-data" source="repec">D</api:keyword><api:keyword origin="record-data" source="repec">I</api:keyword><api:keyword origin="record-data" source="repec">Z</api:keyword><api:keyword origin="record-data" source="repec">I1</api:keyword><api:keyword origin="record-data" source="repec">I19</api:keyword><api:keyword origin="record-data" source="repec">I18</api:keyword><api:keyword origin="record-data" source="repec">I11</api:keyword><api:keyword origin="record-data" source="repec">Modelling</api:keyword><api:keyword origin="record-data" source="repec">Pharmacoeconomics</api:keyword><api:keyword scheme="for" origin="issn-inferred">11 Medical and Health Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">14 Economics</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Health Policy &amp; Services</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3214 Pharmacology and pharmaceutical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3801 Applied economics</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">4203 Health services and systems</api:keyword></api:keywords></api:all-labels><api:journal issn="1170-7690" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037" title="PharmacoEconomics (Auckland)"><api:records><api:record source-name="summary"><api:title>PharmacoEconomics (Auckland)</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1261/relationships"/></api:object></api:result></api:response>